QuantumScape Corp

For the period ended Sep 30, 2026. Filed Oct 23, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 23, 2026

QS$4.45-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

(In Thousands)

Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Three Months Ended September 30, 2026	Shares	Amount	Capital	Deficit	Loss	Equity
Balance as of June 30, 2026	619,109	$62	$5,041,507	$(3,992,603)	$(994)	$1,047,972
Exercise of stock options	69	—	108	—	—	108
Shares issued upon vesting of restricted stock units	2,881	—	—	—	—	—
Stock-based compensation	—	—	14,333	—	—	14,333
Capital contribution under collaboration agreement - related party	—	—	18,503	—	—	18,503
Net loss	—	—	—	(84,477)	—	(84,477)
Unrealized loss on marketable securities	—	—	—	—	(1,095)	(1,095)
Balance as of September 30, 2026	622,059	$62	$5,074,451	$(4,077,080)	$(2,089)	$995,344
Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Nine Months Ended September 30, 2026	Shares	Amount	Capital	Deficit	Income (Loss)	Equity
Balance as of December 31, 2025	607,630	$61	$4,961,832	$(3,793,564)	$644	$1,168,973
Exercise of stock options and employee stock purchase plan	829	—	3,715	—	—	3,715
Shares issued upon vesting of restricted stock units	13,600	1	16,741	—	—	16,742
Stock-based compensation	—	—	63,307	—	—	63,307
Capital contribution under collaboration agreement - related party	—	—	28,856	—	—	28,856
Net loss	—	—	—	(283,516)	—	(283,516)
Unrealized loss on marketable securities	—	—	—	—	(2,733)	(2,733)
Balance as of September 30, 2026	622,059	$62	$5,074,451	$(4,077,080)	$(2,089)	$995,344

Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Three Months Ended September 30, 2025	Shares	Amount	Capital	Deficit	Income (Loss)	Equity
Balance as of June 30, 2025	565,316	$56	$4,612,488	$(3,587,635)	$(113)	$1,024,796
Exercise of stock options	3,218	1	7,985	—	—	7,986
Shares issued upon vesting of restricted stock units	3,326	—	25	—	—	25
Shares issued under At-the-Market Offering, net of issuance costs	29,288	3	263,266	—	—	263,269
Stock-based compensation	—	—	24,840	—	—	24,840
Net loss	—	—	—	(105,824)	—	(105,824)
Unrealized gain on marketable securities	—	—	—	—	656	656
Balance as of September 30, 2025	601,148	$60	$4,908,604	$(3,693,459)	$543	$1,215,748
Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Nine Months Ended September 30, 2025	Shares	Amount	Capital	Deficit	Income	Equity
Balance as of December 31, 2024	542,549	$54	$4,515,879	$(3,358,514)	$428	$1,157,847
Exercise of stock options and employee stock purchase plan	13,178	2	23,643	—	—	23,645
Shares issued upon vesting of restricted stock units	15,927	1	20,264	—	—	20,265
Shares issued under At-the-Market Offering, net of issuance costs	29,494	3	264,173	—	—	264,176
Stock-based compensation	—	—	84,645	—	—	84,645
Net loss	—	—	—	(334,945)	—	(334,945)
Unrealized gain on marketable securities	—	—	—	—	115	115
Balance as of September 30, 2025	601,148	$60	$4,908,604	$(3,693,459)	$543	$1,215,748

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.